Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
IRB 2240400
Approved small_molecule active
Quick answer
Sofosbuvir / Velpatasvir Oral Tablet [Epclusa] for HEPATITIS C (HCV) is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- HEPATITIS C (HCV)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active